Learn
Healthcare
Lack of access to affordable healthcare puts millions of people at risk in America. Complex pricing strategies and patent laws can lead to disproportionate costs for vulnerable members of society.
Stories
Aducanumab, or Aduhelm, is the first new Alzheimer's treatment in 18 years and the first to attack …
1 year, 7 months
ABUJA, Nigeria - Ghana became the first country to receive a shipment of coronavirus vaccine from a…
1 year, 11 months
The Biden administration plans to make good on a promise to donate $4 billion, while the pharmaceut…
1 year, 11 months
The case focuses on two of the company's facilities in New York. New York's attorney general, Letit…
1 year, 11 months
The Justice Department sued Walmart on Tuesday for what it said was the company's role in fueling t…
2 years, 1 month
American employers continue to cut jobs at rates that dwarf the pace of layoffs in past decades, ev…
2 years, 4 months
Experts are concerned that the company has not been more forthcoming about two participants who bec…
2 years, 4 months
FRANKFURT (Reuters) - Nine leading U.S. and European vaccine developers pledged on Tuesday to uphol…
2 years, 4 months
Moderna, which is receiving $483 million from the U.S. government, told lawmakers it would not sell…
2 years, 6 months
Walmart will require customers at all of its US stores to wear masks beginning next week, becoming …
2 years, 6 monthsPetitions
Force Netflix, a big part of Georgia's lucrative film industry, to stop filming there & show there's an economic cost to endangering women's lives.
$442.3 million supporting
Recent ire has surfaced a number of financial and reputational risks to Johnson and Johnson resulting from from high priced pharmaceuticals.
$157.5 million supporting
AbbVie should disclose lobbying activities so shareholders can assess which are consistent with the company's expressed goals.
$1.1 million supporting
Tell Abbvie to explain how it is promoting a solution to public concern over high drug prices
$16,940 supporting
Stay true to your mission to create and commercialize antibiotics.
$0 supporting